Soluble BTN2A1 as a potential predictive biomarker of immune checkpoint inhibitor efficacy in advanced non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Rochigneux, Philippe
Chretien, Anne Sophie
Rossille, Delphine
Chanez, Brice
Billon, Emilien
Fattori, Stephane
Corre, Romain
Pakradouni, Jihane
Goncalves, Anthony
Fest, Thierry
Madroszyk, Anne
Olive, Daniel
机构：
[1] Inst Paoli Calmettes, CRCM U1068, Marseille, France
[2] CRCM, Marseille, France
[3] Univ Hosp Rennes, Rennes, France
[4] Inst Paoli Calmette, Marseille, France
[5] Rennes Univ Hosp, Rennes, France
[6] Inst Paoli Calmettes, Dept Clin Res & Innovat, Marseille, France
[7] Aix Marseille Univ, Inst Paoli Calmettes, Dept Med Oncol, CRCM,CNRS,INSERM, Marseille, France
[8] Inst Paoli Calmettes CRCM U1068, Marseille, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9561
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PREDICTIVE SOLUBLE BIOMARKERS OF IMMUNE RESPONSE TO CHECKPOINT BLOCKADE IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Raza, Afsheen
    Mohsen, Reyad
    Kanbour, Aladdin
    Gul, Abdul Rehman Zar
    Philip, Anite
    Vijayakumar, Suma
    Hydrose, Shereena
    Merhi, Maysaloun
    Inchakalody, Varghese
    Uddin, Shahab
    Al Homsi, Mohammed Ussama
    Dermime, Said
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A19 - A19
  • [2] Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer
    Alice Mogenet
    Pascal Finetti
    Emilie Denicolai
    Laurent Greillier
    Pascaline Boudou-Rouquette
    François Goldwasser
    Gwenael Lumet
    Michele Ceccarelli
    Daniel Birnbaum
    Davide Bedognetti
    Emilie Mamessier
    Fabrice Barlesi
    François Bertucci
    Pascale Tomasini
    Journal of Translational Medicine, 21
  • [3] Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer
    Mogenet, Alice
    Greillier, Laurent
    Denicolai, Emilie
    Barlesi, Fabrice
    Bertucci, Francois
    Finetti, Pascal
    Tomasini, Pascale
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer
    Mogenet, Alice
    Finetti, Pascal
    Denicolai, Emilie
    Greillier, Laurent
    Boudou-Rouquette, Pascaline
    Goldwasser, Francois
    Lumet, Gwenael
    Ceccarelli, Michele
    Birnbaum, Daniel
    Bedognetti, Davide
    Mamessier, Emilie
    Barlesi, Fabrice
    Bertucci, Francois
    Tomasini, Pascale
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [5] Safety and efficacy of immune checkpoint inhibitor rechallenge in advanced non-small cell lung cancer: a retrospective study
    Feng, Jia
    Chen, Xinyi
    Wei, Jiayan
    Weng, Yiming
    Wang, Jingsong
    Wang, Tong
    Song, Qibin
    Min, Peng
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [6] The Lung Immune Prognostic Index (LIPI), a predictive score for immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC) patients
    Mezquita, L.
    Auclin, E.
    Charrier, M.
    Ferrara, R.
    Masip, J. Remon
    Planchard, D.
    Aix, S. Ponce
    Paz-Ares, L.
    Lahmar, J.
    Leroy, L.
    Audigier-Valette, C.
    Cuairan, J. Zeron-Medina
    Lopez, P. Garrido
    Brosseau, S.
    Mazieres, J.
    Caramella, C.
    Adam, J.
    Chaput, N.
    Soria, J-C.
    Besse, B.
    ANNALS OF ONCOLOGY, 2017, 28
  • [7] Effect of antibiotic treatment on immune checkpoint inhibitor efficacy in patients with advanced non-small cell lung cancer
    Alkan, G.
    Oztas, N. Senturk
    Turna, Z. H.
    Ozguroglu, M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1082 - S1082
  • [8] Safety and efficacy of immune checkpoint inhibitor rechallenge in advanced non-small cell lung cancer: a retrospective study
    Jia Feng
    Xinyi Chen
    Jiayan Wei
    Yiming Weng
    Jingsong Wang
    Tong Wang
    Qibin Song
    Peng Min
    Scientific Reports, 14
  • [9] Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma
    Billon, Emilien
    Chanez, Brice
    Rochigneux, Philippe
    Albiges, Laurence
    Vicier, Cecile
    Pignot, Geraldine
    Walz, Jochen
    Chretien, Anne-Sophie
    Gravis, Gwenaelle
    Olive, Daniel
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [10] Is smoking history the truly best biomarker for immune checkpoint inhibitor treatment in advanced non-small cell lung cancer?
    Pirker, Robert
    ESMO OPEN, 2018, 3 (05)
12345